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Abstract
Aneuploidy, a state in which cells exhibit copy number changes of (parts of) chromo-
somes, is a hallmark of cancer cells and, when present in all cells, leads to miscarriages 
and congenital disorders, such as Down syndrome. In addition to these well-known roles 
of aneuploidy, chromosome copy number changes have also been reported in some stud-
ies to occur in neurons in healthy human brain and possibly even more in Alzheimer’s 
disease (AD). However, the studies of aneuploidy in the human brain are currently under 
debate as earlier findings, mostly based on in situ hybridization approaches, could not be 
reproduced by more recent single cell sequencing studies with a much higher resolution. 
Here, we review the various studies on the occurrence of aneuploidy in brain cells from 
normal individuals and Alzheimer’s patients. We discuss possible mechanisms for the 
origin of aneuploidy and the pros and cons of different techniques used to study aneu-
ploidy in the brain, and we provide a future perspective.
Keywords: Alzheimer’s disease, aneuploidy, brain, neurodegeneration, single cell 
sequencing
1. Introduction
Aneuploidy is a state in which cells have an abnormal and unbalanced number of chromo-
somes. An aneuploid cell can have one or more extra chromosomes, called hyperploid, or it 
could have lost one or more chromosomes, which is called hypoploid. Following this defini-
tion of aneuploidy, a cell that has doubled its complete genome without dividing is called 
tetraploid and not aneuploid, because a balanced genome is still present.
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Aneuploidy is well known from cancer and systemic trisomies such as Down syndrome. 
Indeed, at least two out of three cancers exhibit aneuploidy [1–3]. Although it has been 
shown that aneuploidy causes stress and reduces cellular fitness [4–7], cancer cells have 
somehow found a way to cope with aneuploidy and manage to proliferate despite the detri-
mental consequences of aneuploidy. This is known as the aneuploidy paradox [6]. Perhaps 
by selecting numerical chromosomal abnormalities that promote tumor progression in addi-
tion to other structural genomic rearrangements, cancer cells can survive and keep grow-
ing [8, 9]. The profound effect that aneuploidy has on healthy cells is emphasized by the 
fact that, besides sex-chromosome abnormalities, in humans, only three systemic autosomal 
trisomies are compatible with life: trisomy 21 causing Down syndrome, trisomy 13 causing 
Patau’s syndrome and trisomy 18 causing Edward’s syndrome [10–12]. The viability of these 
systemic aneuploidies can probably be explained by the fact that these three chromosomes 
contain the lowest number of genes of all human autosomes. Even though these trisomies 
can be compatible with life, the majority of such trisomic pregnancies end with a miscarriage, 
and the children that do survive until birth suffer from severe cognitive and developmental 
defects [13].
But what is the origin of aneuploid cells? Aneuploidy is the result of chromosomal instability 
(CIN) and can arise when errors occur during DNA replication or mitosis. To prevent such 
errors, cells have evolved many checkpoints and mechanisms that ensure faithful replication 
of DNA and proper chromosome segregation. One of these checkpoints, the spindle assembly 
checkpoint (SAC), ensures that chromosome segregation is prevented until all chromosomes 
are properly attached to the mitotic spindle. Therefore, when the SAC fails, daughter cells can 
end up with gained or lost chromosomes. Furthermore, merotelic attachments—chromosome 
attachments where one of the sister chromatids is attached to both spindle poles—can result 
in aneuploidy even with a functional SAC. Finally, several other mechanisms, such as cohe-
sion defects, multipolar spindles and lagging chromosomes, can all lead to incorrect chromo-
some segregation and thus aneuploidy [14].
Many tumor cells have inactivated the tumor suppressor p53, a key transcription factor in 
the DNA damage response and other cell cycle checkpoints. When functional, stresses such 
as DNA damage lead to activation of p53. P53 then induces a cell cycle arrest and activates 
DNA repair or induces apoptosis when the damage cannot be repaired. Loss of p53 makes 
cells more tolerant of aneuploidy [15] and allows them to propagate despite DNA damage or 
short telomeres [16].
When telomeres become too short, following proliferation or due to defects in telomere 
function, cells exit the cell cycle [17]. Loss of p53 overcomes this tumor suppression mech-
anism and allows cells to proliferate with critically short telomeres. This results in end-
to-end fusion of sister chromatid telomeres, resulting in dicentric chromosomes. Dicentric 
chromosomes are likely to missegregate during mitosis, thus resulting in aneuploidy and 
DNA breaks. Such broken chromosomes can trigger a so-called breakage-fusion-bridge 
(BFB) cycle, which can continue over many cell divisions, leading to large duplications and 
deletions and very heterogeneous aneuploidy in cells [18]. Altogether, many processes, 
alone or in combination, can yield cells with whole chromosome or segmental chromosomal 
changes.
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2. Aneuploidy during development and aging
Studying aneuploidy in the brain is complicated by the largely postmitotic state of adult neu-
rons, limiting the methods that can be used. Therefore, many studies have used methods like 
interphase FISH, or DNA dyes such as DAPI or PI in combination with, for example, flow 
cytometry to determine the DNA/genome content of individual cells. Given the detrimental 
effect that aneuploidy has on cells, one would expect somatic cells of the brain to be perfectly 
euploid. A publication by Rehen et al. in 2001 challenged this view [19]. In this study, the 
authors quantified aneuploidy in embryonic mouse neuroblasts, adult cortex and lympho-
cytes using spectral karyotyping (SKY) and fluorescence in situ hybridization (FISH). They 
found ~33% of the 220 mouse neuroblast metaphase cells studied to be aneuploid as assessed 
by SKY, the great majority of which was hypoploid (98%). In contrast, of the adult mouse 
lymphocytes only 3% of the metaphase cells were identified as being aneuploid. In the same 
study, X and Y chromosome aneuploidy was assessed using FISH in adult mouse brain. They 
found X or Y chromosome aneuploidy occurring in 1.2% of the brain cells examined. The same 
rate of aneuploidy was found when comparing total adult nuclei with nuclei ≥10 μm, which 
are likely to be neurons. In comparison, the rate of X and Y chromosome aneuploidy in the 
mouse neuroblasts was ~10% (of which ~8% loss and 2% gain) [19]. In summary, these results 
suggest a high rate of aneuploidy in the developing mouse brain, and a much lower but still 
significant number of aneuploid cells in the adult mouse brain [20, 21]. A number of other 
studies reported similar aneuploidy rates in the developing human brain using interphase 
FISH. Aneuploidy rates up to 30–35% in the (developing) human brain were found, some 
studies reporting mainly chromosome losses [22, 23], another mainly chromosome gains [21]. 
The cause of aneuploidy in the developing brain was speculated to be mitotic segregation 
defects, since in dividing mouse neuronal progenitor cells lagging chromosomes and multi-
polar spindles have been found [24]. In contrast, there is little consistency in the aneuploidy 
rates reported in adult human brain. For example, the percentages of aneuploidy range from 
0 up to 40: no aneuploidy was found in 2 normal brains (n = 200/chromosome/sample) [25], 
~4% aneuploidy of chromosome 21 (n = 500–1000 per sample) [26], 1.3–7.0% aneuploidy per 
chromosome (n ≥ 500 for adult and ≥1000 for embryonic samples for each chromosome) [22] 
and 40% aneuploidy in the normal human brain (n = NA) [27]. All of these studies used FISH 
to count the chromosomes. A study performed by the group of Rehen, which combined sev-
eral techniques, reported that aneuploid neurons seem to be integrated into the brain circuity 
like euploid cells and that aneuploid neurons can be activated and seem to be functional [28]. 
Taken together, although the rate of aneuploidy reported varies widely, most reports state 
that, especially in the developing brain, aneuploid cells are present at detectable frequencies 
in the normal brain.
But if aneuploid cells are present in large numbers in the developing brain, and in lower quan-
tities in the adult human brain, what happens during aging? An increase in aneuploidy for 
chromosome 17 and 21 was found in the hippocampus of aged individuals compared to young 
controls [29]. In sharp contrast, another study determined the number of cells with a DNA 
content above the diploid level in brain samples ranging from 30 to 90 years of age. They found 
a decrease in the number of cells exceeding the diploid level with age [30], but suggested that 
this might be due to a biased selection of “healthy aging” brains. Taken together, there appears 
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to be little consensus on whether aneuploid cells are present in adult brains, their frequency, 
and changes during aging. An overview of previous studies on aneuploidy in the brain is 
shown in Table 1. To explain the high rates of aneuploidy in the brain, several of the above-
discussed studies hypothesized that aneuploidy in fact might contribute to neuronal diversity. 
Species/cell type Technique(s) used Chromosomes studied Main conclusions Reference
Mouse neuroblasts 
and adult cortical 
cells
SKY, FISH, FACS All chromosomes ~33% aneuploidy in 
neuroblasts, of which 
98% hypoploidy, 
1.2% X/Y aneuploidy 
in adult cortical cells
Rehen et al. [19]
Undiseased human 
prefrontal cortical 
(area 10) neurons
FISH 1, 7, 8, 13, 16, 18, 21, 22, 
X and Y
No aneuploidy found Yurov et al. [25]
Human hippocampal 
pyramidal cells of 
AD patients and age 
matched controls
FISH 11, 18 and 21 3 or 4 hybridization 
spots in 3.7% of 
cells in AD, no cells 
with more than 2 
hybridization spots 
in controls
Yang et al. [51]
Mouse neuronal 
progenitor cells
SKY All chromosomes 33.2% aneuploidy Yang et al. [37]
Mouse subventricular 
zone (SVZ) cells
DAPI staining, 
SKY
All chromosomes 33% aneuploidy in 
SVZ cells, of which 
~76% hypoploidy 
with the majority 
having lost multiple 
chromosomes
Kaushal et al. [24]
Human neurons and 
nonneuronal brain 
cells
FISH 21 4% aneuploidy of 
chromosome 21, 
mean chromosome 
number of 2.05, no 
difference between 
neurons and 
nonneuronal cells
Rehen et al. [26]
Mouse cortical 
neurons
FISH X and Y ~0.2% combined 
hyperploidy
Kingsbury et al. [28]
Human (undiseased 
and AD) and mouse 
neurons
FISH Not stated 43% (32–53%) 
aneuploidy in AD 
neurons, 40% (38–
47%) in undiseased 
neurons, similar 
degree in murine 
neurons (data not 
shown)
Pack et al. [27]
Human brain cells 
from fetal tissue 
(medulla oblongata) 
and adult cortex 
(area 10)
FISH 1, 13/21, 18, X and Y 0.6–3.0% aneuploidy 
per chromosome 
in fetal brain cells, 
0.1–0.8% aneuploidy 
per chromosome in 
adult brain cells
Yurov et al. [22]
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Species/cell type Technique(s) used Chromosomes studied Main conclusions Reference
Human entorhinal 
cortical neurons from 
patients with AD and 
controls
SBC, CISH Overall DNA content 
and 17
Increased 
hyperploidy in 
AD, increased 
hybridization spots 
for chromosome 17 
in AD
Mosch et al. [41]
Human fetal brain FISH 1, 9, 15, 16, 17, 18, X 
and Y
1.25–1.45% 
aneuploidy per 
chromosome
Yurov et al. [23]
Human buccal and 
hippocampal cells 
from AD patients and 
controls
FISH 17 and 21 Increased aneuploidy 
in buccal cells of AD 
patients but not in 
hippocampus
Thomas et al. [29]
Mouse NPCs and 
human and mouse 
cerebellum
DAPI staining, 
FISH
Mouse: 16 and X
Human: 6 and 21
15.3% aneuploidy in 
mouse NPCs at P0, 
20.8% at P7, 0.5–1.0% 
aneuploidy per 
chromosome in adult 
mouse and human 
NeuN+ and NeuN−
cerebellar nuclei
Westra et al. [88]
Cerebral cortex of 
normal human brain 
and AD patients
FISH 1, 7, 11, 13, 14, 17, 18, 
21, X and Y
0.5% aneuploidy 
per chromosome in 
normal and AD brain, 
except increased 
chromosome 21 
aneuploidy in AD: 
6–15%
Iourov et al. [64]
Cortical and 
hippocampal nuclei 
of normal human 
brain and AD 
patients
FISH 4, 6 and 21 0.4–3.5% tetrasomy in 
nonneuronal cells No 
difference in normal 
and AD brain in 
nonneuronal cells, no 
tetrasomy in neurons
Westra et al. [52]
Entorhinal cortex of 
normal, preclinical 
AD, mild AD and 
severe AD patients
SBC, FISH, CISH Overall DNA content 
and 17
10% hyperploidy in 
normal brain, ~27% 
in preclinical AD, 
~35% in mild AD and 
~23% in severe AD
Arendt et al. [63]
Cerebral and 
cerebellar cortex of 
young and old mice
FISH 1, 7, 14, 15, 16, 18, 19 
and Y
1% aneuploidy per 
chromosome in 
cerebral cortex of 
young mice, 2.3% in 
old mice, no increase 
in aneuploidy with 
age in cerebella
Faggioli et al. [20]
Neurons and NPCs 
derived from human 
induced pluripotent 
stem cells and normal 
human frontal cortex
Single cell 
sequencing, FISH
All chromosomes 20 
and X with FISH
27.5% aneuploidy 
in hiPSC-derived 
neurons, 5% in 
hiPCS-derived NPCs, 
2.7% aneuploidy in 
normal frontal cortex
McConnell et al. [82]
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The human brain consists of approximately 100 billion neurons forming an estimated 0.15 qua-
drillion (1015) synapses, and there is a very high diversity of neurons [31]. Human brains have 
a high level of cellular heterogeneity, and it has been estimated that our brains might have 
as many as 10,000 different types of neurons [32]. All these different neurons work together 
to allow us to perform complex tasks. It is suggested that the presence of aneuploid neurons 
could be one of the mechanisms providing more variability and complexity to the human 
brain [14, 32–34].
3. Origin of aneuploid cells in the brain
If our brain indeed contains aneuploid cells, where do they originate? As discussed above, 
aneuploid cells are usually formed when something goes wrong with DNA replication or in 
mitosis. Aneuploid cells could therefore be generated during early development when there 
Species/cell type Technique(s) used Chromosomes studied Main conclusions Reference
Prefrontal cortex of 
normal brain and AD 
patients
FISH 1, 7, 11, 16, 17, 18 and X Increased X 
chromosome 
aneuploidy in AD 
(1.16–1.74% in 
controls, 2.78–4.92% 
in AD)
Yurov et al. [65]
Human cortical 
neurons
Single cell 
sequencing
All chromosomes 5% aneuploidy 
in normal human 
cortical neurons
Cai et al. [81]
Mouse embryonic 
NPCs and adult 
brain, human frontal 
cortex
Single cell 
sequencing
All chromosomes No aneuploidy 
in mouse NPCs 
and neurons, 2.3% 
aneuploidy in adult 
mouse brain, 2.2% 
aneuploidy in human 
brain
Knouse et al. [87]
Mouse embryonic 
and adult cerebral 
and cerebellar cortex
FISH 1, 7, 18 ~1% (cerebral) and 
0.1% (cerebellar) 
aneuploidy per 
chromosome in 
14 weeks and 
6-month-old mice, 
~30% aneuploidy per 
chromosome (chr. 1 
and 18) in embryonic 
mouse brain
Andriani et al. [21]
Prefrontal cortical 
neurons of normal 
brain and AD 
patients
Single cell 
sequencing
All chromosomes No increased 
aneuploidy in AD: 
0.7% aneuploidy in 
controls, 0.6% in AD
van den Bos et al. [66]
Table 1. Overview of studies on aneuploidy in the brain.
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is a high rate of cell division, or later in life during normal or abnormal cell division. We can 
think of a number of explanations. First, since especially in the developing brain high rates of 
aneuploid cells have been found, defective clearance of these cells could explain their pres-
ence in the adult brain [35]. During brain development, many more cells are formed than end 
up in the adult brain suggesting the existence of strong selection for certain cell types [36]. 
This process possibly includes negative selection for aneuploid cells, which could explain 
the much lower rate of aneuploidy reported in the adult brain than in the developing brain. 
Failure to select for diploid cells during this selection could result in aneuploid cells being 
present in the adult brain [37, 38]. Indeed, in vitro experiments have shown that the differen-
tiation of pluripotent stem cells into neural progenitor cells by retinoic acid (RA) is accompa-
nied by increased levels of aneuploidy and micronuclei [39]. Second, it has been hypothesized 
that cell cycle reentry and failure to complete the cell cycle of neurons might be involved in 
neurodegeneration [40–43]. Neurons might attempt to reenter the cell cycle, replicate their 
DNA but fail to complete cell division. The main evidence for this hypothesis is the observa-
tion that postmitotic neurons in AD brains sometimes stain positive for cell cycle markers 
such as PCNA, cyclins and cyclin depended kinases (CDKs) [44–50]. As a consequence of 
reentering the cell cycle, the presence of tetraploid cells in the brain is expected. These cells 
have completed DNA replication but are unable to complete mitosis. But whether tetraploid 
cells are indeed present in the brain is still under debate [51, 52]. By counting fluorescent 
signals from probes directed at either chromosome 11, 18 or 21, Yang et al., found that 3.7% 
of the hippocampal cells in six AD brains have displayed three or four fluorescent signals. 
Although the fluorescent probes were not combined on individual cells, no distinction was 
made between three and four fluorescent signals, and no neuronal marker or DNA counter 
stain was used; the researchers conclude from these results that 3.7% of the hippocampal 
cells in these AD brains have a fully or partially replicated genome. But these results can 
also reflect single chromosome aneuploidies [51]. In contrast, a study performed by Westra 
et al. failed to find any tetraploid neurons in the cells studied [52], the only cells with four 
fluorescent signals were nonneuronal, and no difference was found between AD and control 
samples. Also, this hypothesis of aberrant cell cycle reentry is not supported by the single 
chromosome aneuploidies found of which, in most cases, only one copy of one chromosome 
is lost or gained in a cell. Third, the limited amount of neurogenesis taking place in the adult 
brain could potentially be a source of aneuploid neurons [39, 53]. In summary, aneuploid 
neurons in the adult brain can have originated in the developing brain and escaped clearing 
mechanisms, or formed due to cell cycle reentry and failed mitosis of adult neurons although 
the evidence for this hypothesis is contrasting.
4. Aneuploidy in neurodegeneration
Because human brain tissue is inaccessible in vivo, many researchers used peripheral cells, 
such as lymphocytes and fibroblasts, to study the correlation between genomic damage 
and neurodegenerative diseases such as AD. Several studies with conflicting results have 
been published: some show a correlation between AD and increased peripheral aneuploidy 
[54–58], while others report no difference [59, 60]. Counting the presence of micronuclei is 
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a way to assess genome stability. Micronuclei are formed when chromosome segregation is 
flawed, causing a part of or a whole chromosome to end up outside of the nucleus in a so-
called micronucleus. Therefore, the number of micronuclei present is a marker for chromo-
some missegregation. Interestingly, AD patients were found to have increased numbers of 
micronuclei in their lymphocytes, mostly containing whole chromosomes [61]. More specifi-
cally, AD patients were reported to have increased rates of trisomy 21 in lymphocytes, while 
missegregation rates for chromosome 13 were unaltered, when compared to healthy con-
trols [62]. Similarly, patients suffering from AD were found to exhibit frequent copy number 
changes for chromosomes 17 and 21 in buccal cells [29].
Since neurons are postmitotic, methods requiring dividing cells to determine chromosome 
copy numbers cannot be used when studying aneuploidy in neurons. Most studies therefore 
make use of fluorescence in situ hybridization (FISH)-based methods to count chromosomes 
in brain cells. When comparing control brain with early and late AD samples using slide-
based cytometry (SBC), PCR amplification of alu repeats, and chromogenic in situ hybrid-
ization (CISH), a twofold increase in neurons with a DNA content between 2 and 4 n was 
found [41]. Also in preclinical stages of AD, an increased number of neurons with a more 
than diploid DNA content have been reported [63]. Iourov et al. found no overall significant 
difference in aneuploidy rates when looking at copy number changes of seven autosomes 
(chromosomes 1, 7, 11, 13, 14, 17 and 18) and the X and Y chromosome. But a specific increase 
in chromosome 21 aneuploidy in neurons of AD brain samples was identified, of which 60% 
where gains and 40% loss of chromosome 21 [64]. On the other hand, in a recent study, a 
twofold increase in X chromosome aneuploidy was found in AD neurons when compared to 
age matched controls [65]. To summarize, although again the rates of aneuploidy and which 
chromosomes are affected differ between studies, the overall trends suggest that aneuploidy 
might be increased in AD [66].
5. The possible link between Down syndrome and Alzheimer’s disease
Down syndrome is the most common autosomal systemic aneuploidy. Besides the obser-
vation of increased levels of trisomy 21 in the brains of AD patients, Down syndrome 
and AD have more in common. First, Down syndrome patients are much more likely to 
develop AD and at an earlier age than genetic euploid individuals [67]. This could be 
related to the fact that the amyloid precursor protein (APP) gene, mutations in which are 
known to cause early onset AD, is located on chromosome 21 [68]. Also, in the brains of 
individuals with Down syndrome over 40 years of age protein aggregates, plaques and 
tangles, are present in amounts that are also observed in AD patients brains [69]. On the 
other hand, not all patients with trisomy 21 over 40 develop AD, although all of them 
develop plaques and tangles [70]. Second, it has been found that young mothers (<35 
years) of a child with Down syndrome have increased chromosomal instability, as shown 
by having more micronuclei [71], and more chromosomal missegregation events in their 
lymphocytes [72]. In the great majority of cases (95%) the extra chromosome 21 originates 
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from a maternal nondisjunction event [73, 74]. Moreover, Schupf et al. found that young 
mothers of a child with Down syndrome have a fivefold increased risk to develop AD, 
while the risk was not increased in mothers who had a child with Down syndrome at a 
later age (>35 years). It is therefore hypothesized that some women might have a genetic 
susceptibility to chromosome nondisjunction, increasing the risk of both getting a child 
with Down syndrome as well as developing AD [75, 76]. Lastly, also mouse models for 
Down syndrome display characteristics of AD [67]. For example, the widely used mouse 
model Ts65Dn, which has an extra copy of a large part of Mmu16, the mouse homolog of 
a large part human chromosome 21 including APP, displays increased levels of APP and 
Aβ, as well as progressive memory decline and neurodegeneration in adult mice [77–79].
6. How can aneuploid cells play a role in neurodegeneration?
Aneuploidy was shown to reduce cellular fitness [80]. It was therefore suggested that aneu-
ploid cells might be selectively affected by cell death in the brains of AD patients. According 
to this hypothesis, a decrease in aneuploidy rates might be expected as the disease progresses. 
This is in line with the observation by Arendt et al. of decreased hyperploidy in severe AD 
compared to mild AD [63]. It must be noted that in this study, the total amount of DNA was 
studied with a DNA dye, rather than the rate of aneuploidy. On the other hand, if aneuploid 
cells remain present in the aging brain, aneuploidy could contribute to neurodegenerative 
diseases through proteotoxic stress. Misfolding of proteins leads to proteotoxic stress, the 
formation of protein aggregates and possibly neurodegeneration. Being aneuploid is a heavy 
burden for a cell. Having an extra copy of a chromosome generally means that the genes on 
this chromosome are transcribed and translated at the same rate compared to the two “nor-
mal” copies. Therefore, the cell has to deal with this 50% extra mRNA and protein [4, 7]. All 
these extra proteins have to be folded into the right conformation or processed by the protein 
degradation machinery. This leads to increased pressure on chaperones and the protein deg-
radation machinery [5, 6]. Since protein aggregates are thought to play an important role in 
the development and progression of many neurodegenerative diseases, their formation might 
be stimulated by excess proteins that overload the protein folding and degradation machin-
ery. Trisomy 21 has been reported to be more prevalent in the brains of AD patients. The extra 
copy of the APP gene on chromosome 21, which encodes the β-amyloid protein, could trigger 
the formation of amyloid plaques resulting in proteotoxic stress and ultimately cell death [68].
7. Low levels of aneuploidy found in the brain using single cell 
sequencing
Recently, it became possible to use single cell next generation sequencing (NGS) to look at 
aneuploidy in individual cells (Figure 1) [81, 82]. Compared to the classic method for mea-
suring aneuploidy using FISH, single cell sequencing has some important advantages [83]. 
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First, FISH studies are in most cases limited to examining only a few chromosomes per cell. 
Therefore, the total rate of aneuploidy is usually determined by extrapolating the aneuploidy 
rates of the few chromosomes that are studied, possibly resulting in an over- or underestima-
tion of the frequency of aneuploidy. With single cell sequencing, the copy number of all chro-
mosomes in each single cell can be determined more accurately. Each chromosome is sampled 
thousands of times, whereas with FISH the chromosomes are usually measured only once or 
twice. Although spectral karyotyping (SKY) can also be used to count all chromosomes within 
a cell, this method requires metaphase chromosomes and thus dividing cells, while single 
cell sequencing can be performed on nondividing cells [84]. Moreover, SKY is more likely to 
overestimate chromosome loss, due to chromosomes being washed away from the slide onto 
which they were dropped. This could explain the high rates of hypoploid cells found using 
SKY [19]. Second, since with FISH the karyotype is determined by simply counting the num-
ber of fluorescent spots, in several ways this can lead to errors in chromosome counts. Failure 
of the probe to hybridize can lead to underestimation, while nonspecific binding results in 
overestimation of aneuploidy rates.
Fortunately, the development of single cell sequencing protocols has allowed studies of all 
chromosomes in single, nondividing cells. For this approach, libraries are made of individual 
cells or nuclei. In most cases, library preparation starts with a whole genome amplification 
step. This can be problematic because uneven amplification of genomic DNA may result in a 
sequencing bias. Next, the DNA is fragmented either mechanically, such as by sonication, or 
Figure 1. Single cell sequencing of a female cell with trisomy of chromosome 21 (A) and a male diploid cell (B). Plots are 
made using Aneufinder [89].
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enzymatically, for example with restriction enzymes. To enable binding of the fragments to 
the sequencing flow cell, adapters are ligated to either end of the fragmented DNA. Also, indi-
vidual barcodes can be introduced to allow pooling (multiplexing) of more than one library 
on a flow cell, thus significantly reducing sequencing costs. After sequencing, the individual 
reads are split into libraries for each individual cell based on the cellular barcode (demulti-
plexing), and the copy numbers of individual chromosomes can be determined by comparing 
the read density on each chromosome. An extra copy of a chromosome is expected to result 
in 50% increase in read density, while loss of a chromosome leads to a 50% reduction of the 
read density on that chromosome [66, 85, 86]. Depending on the sequencing depth, single 
cell sequencing can, in addition to whole chromosome aneuploidies, also reveal smaller copy 
number changes. Since single cell sequencing is often combined with FACS sorting of single 
nuclei, micronuclei will be lost when sorting nuclei. Also, this method is relatively expensive 
and thereby limits large-scale sequencing projects. Even though only few studies so far used 
next generation sequencing based on karyotype cells, the results are contrasting some of the 
earlier FISH-based findings in that the rate of aneuploidy found was in general much lower 
than was reported previously. For instance, Knouse et al. identified one aneuploid brain cell 
of the 43 sequenced cells, and all of the nine neurons sequenced were euploid [87]. Another 
study found five neurons to be aneuploid out of the 100 neurons that passed the quality 
criteria [81]. Also, only one chromosomal gain and 2 losses were identified in 110 sequenced 
frontal cortex neurons of 3 individuals [82]. Finally, the largest study determined aneuploidy 
rates in postmortem frontal cortex neurons of normal human brain and samples from patients 
affected with AD. Interestingly, a very limited number of aneuploid neurons was found; <1% 
aneuploidy both in controls and AD [66]. All of these single cell sequencing studies use cells 
of which the chromosome copy numbers are known as validation of the method: human male 
trisomy 21 fibroblasts [82], human male trisomy 18 neurons [81], mouse trisomy 16 brain cells 
[87] and human female trisomy 21 neurons [66]. In each case, the known aneuploidy as well 
as the correct number of X chromosomes, male or female, was detected with 100% accuracy, 
confirming the sensitivity of single cell sequencing. Studying aneuploidy in the developing 
human brain with single cell sequencing remains to be done. But also here, the lack of aneu-
ploidy reported in the 36 mouse neuronal progenitor cells sequenced might be an indica-
tion that also the embryonic aneuploidy levels have been overestimated [87]. Taken together, 
the results of single cell sequencing studies are in sharp contrast to the previously reported 
aneuploidy rates. How can these conflicting results obtained with different techniques be 
explained? As mentioned before, studies of aneuploidy in the human brain are complicated. 
Selecting a tissue or cell type as valid control is difficult, as no tissue is similar to brain tissue. 
Usually, lymphocytes are used as control. This potentially introduces problems, as the isola-
tion of cells or nuclei from such very different sources requires very different experimental 
approaches: lymphocytes are isolated as single, unattached cells, while brain tissue needs 
some sort of mechanical or enzymatic dissociation to obtain individual cells or nuclei. On the 
other hand, brain tissue sections can also be used, but in this case, the inevitable cuts through 
nuclei can give rise to incorrect chromosome counts. While differences in handling of the 
tissue or cells may explain some of the reported differences, this explanation does not apply 
when comparing aneuploidy in normal and diseased brain samples.
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8. Conclusion
The frequency of neuronal aneuploidy in the normal healthy brain remains a matter of 
debate. Although many studies report a certain level of aneuploidy, this is not confirmed by 
more recent reports using single cell sequencing. Whether the number of aneuploid cells is 
increased or decreased with aging and in neurodegenerative diseases remains to be conclu-
sively shown. Aneuploid neurons could be involved in neurodegeneration because an incor-
rect karyotype could cause proteotoxicity via protein misfolding and aggregation. Single cell 
sequencing is a promising tool to address questions about aneuploidy in the brain and should 
provide more definite answers in the years to come.
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